Predictive Value of Serum Inflammatory Biomarkers in Postmenopausal Osteoporosis: A Cross-sectional Study in Northwest Iran

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Sep 12

PMID 39263180

Authors

Somayyeh Sarrafi

Leila Vahedi

Samira Pourzainali

Minoo Ranjbar

Azizeh Farshbaf-Khalili

Soraya Babaie

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to compare the inflammatory biomarkers in postmenopausal women with osteoporosis and those with normal bone mineral density (BMD). A total of 850 postmenopausal women aged 50 to 65 were randomly selected for participation in this cross-sectional investigation. 100 women displayed normal BMD, while 101 were diagnosed with osteoporosis, as determined by dual-energy X-ray absorptiometry. Biochemical techniques were used to quantify tumor necrosis factor α (TNF-α) levels, high-sensitivity C-reactive protein (hs-CRP), and interleukin-6. The area under the curve (AUC) for the diagnosis of osteoporosis was calculated using receiver-operator characteristic (ROC) curves. A significant difference was observed between the two groups in terms of age, menopause age, education level, and BMI (p < 0.005). Moreover, TNF-α ( = 0.026) and hs-CRP ( < 0.001) levels were significant differences between two groups. The logistic regression analysis adjusted for the confounders showed that only the elevation of hs-CRP had a significant effect on the risk of osteoporosis (OR (95 % CI):42.41 (12.66-142.3), < 0.001). ROC analysis demonstrated that at the cut-off point of 0.415, the sensitivity and specificity values of 83.2 % and 82.2 % were obtained, respectively, for hs-CRP. hs-CRP is a valuable test for screening osteoporosis in postmenopausal women due to its accuracy and cost-effectiveness.

References

Kimble R, Bain S, Pacifici R . The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res. 1997; 12(6):935-41. DOI: 10.1359/jbmr.1997.12.6.935. View

Biglia N, Cagnacci A, Gambacciani M, Lello S, Maffei S, Nappi R . Vasomotor symptoms in menopause: a biomarker of cardiovascular disease risk and other chronic diseases?. Climacteric. 2017; 20(4):306-312. DOI: 10.1080/13697137.2017.1315089. View

Yalin S, Bagis S, Polat G, Dogruer N, Cenk Aksit S, Hatungil R . Is there a role of free oxygen radicals in primary male osteoporosis?. Clin Exp Rheumatol. 2005; 23(5):689-92. View

Prystaz K, Kaiser K, Kovtun A, Haffner-Luntzer M, Fischer V, Rapp A . Distinct Effects of IL-6 Classic and Trans-Signaling in Bone Fracture Healing. Am J Pathol. 2017; 188(2):474-490. DOI: 10.1016/j.ajpath.2017.10.011. View

Del Giudice M, Gangestad S . Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain Behav Immun. 2018; 70:61-75. DOI: 10.1016/j.bbi.2018.02.013. View

McMahon M, Ueki Y . Does anti-TNF-alpha have a role in the treatment of osteoporosis?. Bull NYU Hosp Jt Dis. 2008; 66(4):280-1. View

Safari A, Borhani-Haghighi A, Dianatpour M, Heydari S, Foroughinia F, Ranjbar Omrani G . Circulating Serum Amyloid A, hs-CRP and Vitamin D Levels in Postmenopausal Osteoporosis. Galen Med J. 2021; 8:e1548. PMC: 8343903. DOI: 10.31661/gmj.v8i0.1548. View

Kawaguchi H, Pilbeam C, Vargas S, MORSE E, Lorenzo J, Raisz L . Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest. 1995; 96(1):539-48. PMC: 185228. DOI: 10.1172/JCI118066. View

Riou B, Rothmann C, Lecoules N, Bouvat E, Bosson J, Ravaud P . Incidence and risk factors for venous thromboembolism in patients with nonsurgical isolated lower limb injuries. Am J Emerg Med. 2007; 25(5):502-8. DOI: 10.1016/j.ajem.2006.09.012. View

10.

Sugimoto T, Sato M, Dehle F, Brnabic A, Weston A, Burge R . Lifestyle-Related Metabolic Disorders, Osteoporosis, and Fracture Risk in Asia: A Systematic Review. Value Health Reg Issues. 2016; 9:49-56. DOI: 10.1016/j.vhri.2015.09.005. View

11.

Kaiser K, Prystaz K, Vikman A, Haffner-Luntzer M, Bergdolt S, Strauss G . Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma. Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(5):523-536. PMC: 5889421. DOI: 10.1007/s00210-018-1483-7. View

12.

Sesso H, Wang L, Buring J, Ridker P, Gaziano J . Comparison of interleukin-6 and C-reactive protein for the risk of developing hypertension in women. Hypertension. 2006; 49(2):304-10. DOI: 10.1161/01.HYP.0000252664.24294.ff. View

13.

Zheng S, Vrindts Y, Lopez M, De Groote D, Zangerle P, Collette J . Increase in cytokine production (IL-1 beta, IL-6, TNF-alpha but not IFN-gamma, GM-CSF or LIF) by stimulated whole blood cells in postmenopausal osteoporosis. Maturitas. 1997; 26(1):63-71. DOI: 10.1016/s0378-5122(96)01080-8. View

14.

Pansini F, Mollica G, Bergamini C . Management of the menopausal disturbances and oxidative stress. Curr Pharm Des. 2005; 11(16):2063-73. DOI: 10.2174/1381612054065819. View

15.

Ganesan K, Teklehaimanot S, Tran T, Asuncion M, Norris K . Relationship of C-reactive protein and bone mineral density in community-dwelling elderly females. J Natl Med Assoc. 2005; 97(3):329-33. PMC: 2568626. View

16.

Pasco J, Kotowicz M, Henry M, Nicholson G, Spilsbury H, Box J . High-sensitivity C-reactive protein and fracture risk in elderly women. JAMA. 2006; 296(11):1353-5. DOI: 10.1001/jama.296.11.1353. View

17.

Chapurlat R, Bui M, Sornay-Rendu E, Zebaze R, Delmas P, Liew D . Deterioration of Cortical and Trabecular Microstructure Identifies Women With Osteopenia or Normal Bone Mineral Density at Imminent and Long-Term Risk for Fragility Fracture: A Prospective Study. J Bone Miner Res. 2019; 35(5):833-844. PMC: 9328422. DOI: 10.1002/jbmr.3924. View

18.

Rose-John S, Jenkins B, Garbers C, Moll J, Scheller J . Targeting IL-6 trans-signalling: past, present and future prospects. Nat Rev Immunol. 2023; 23(10):666-681. PMC: 10108826. DOI: 10.1038/s41577-023-00856-y. View

19.

Damani J, De Souza M, Strock N, Koltun K, Williams N, Weaver C . Associations Between Inflammatory Mediators and Bone Outcomes in Postmenopausal Women: A Cross-Sectional Analysis of Baseline Data from the Prune Study. J Inflamm Res. 2023; 16:639-663. PMC: 9939790. DOI: 10.2147/JIR.S397837. View

20.

Craig C, Marshall A, Sjostrom M, Bauman A, Booth M, Ainsworth B . International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003; 35(8):1381-95. DOI: 10.1249/01.MSS.0000078924.61453.FB. View